164 related articles for article (PubMed ID: 32763234)
1. Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units.
Yamada CH; Telles JP; Oliveira DDS; Cieslinski J; Ribeiro VST; Gasparetto J; Tuon FF
Braz J Infect Dis; 2020; 24(4):356-359. PubMed ID: 32763234
[TBL] [Abstract][Full Text] [Related]
2. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
3. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study.
Xu J; Duan L; Li J; Chen F; Xu X; Lu J; Zhuang Z; Cao Y; Yuan Y; Liu X; Sun J; Zhou Q; Shi L; Tang L
BMC Infect Dis; 2022 Aug; 22(1):667. PubMed ID: 35918657
[TBL] [Abstract][Full Text] [Related]
6. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
Lin H; Yeh DD; Levine AR
Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: an observational study in intensive care unit patients.
Saugel B; Gramm C; Wagner JY; Messer M; Lahmer T; Meidert AS; Schmid RM; Huber W
J Crit Care; 2014 Jun; 29(3):351-5. PubMed ID: 24456810
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
Bissell BD; Riggi G; Morrison C
J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
[TBL] [Abstract][Full Text] [Related]
9. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
10. Importance of vancomycin loading doses in intermittent infusion regimens.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
[TBL] [Abstract][Full Text] [Related]
11. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
Blot S; Koulenti D; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J; Roberts JA
Crit Care; 2014 May; 18(3):R99. PubMed ID: 24887569
[TBL] [Abstract][Full Text] [Related]
12. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
13. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
14. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A
Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
[TBL] [Abstract][Full Text] [Related]
17. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
